Lymph node ratio as a survival predictor for head and neck squamous cell carcinoma with multiple adverse pathological features

© 2023 Wiley Periodicals LLC..

BACKGROUND: The study investigates the prognostic significance of lymph node ratio (LNR) on patients with head and neck squamous cell carcinoma (HNSCC) with coexistence of multiple adverse pathological features.

METHODS: In total, 100 patients with coexistence of perineural invasion, lymphovascular invasion, and extranodal extension of first primary HNSCC treated with radical surgery followed by adjuvant chemoradiotherapy were enrolled.

RESULTS: The optimal LNR cut-off value for predicting overall survival (OS) and cancer specific survival (CSS) was 7%. In Cox model, we observed that LNR ≥7% was a statistically significant unfavorable predictor of OS (HR: 2.689; 95% CI: 1.228-5.889; p = 0.013) and CSS (HR: 3.162; 95% CI: 1.234-8.102; p = 0.016).

CONCLUSION: For HNSCC patients with coexistence of multiple adverse pathological features, LNR is an independent survival predictor. Novel intensified treatments are needed for the subgroup of patients with a high LNR.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:45

Enthalten in:

Head & neck - 45(2023), 8 vom: 21. Aug., Seite 2017-2027

Sprache:

Englisch

Beteiligte Personen:

Tsai, Ming-Hsien [VerfasserIn]
Chuang, Hui-Ching [VerfasserIn]
Chien, Chih-Yen [VerfasserIn]
Huang, Tai-Lin [VerfasserIn]
Lu, Hui [VerfasserIn]
Su, Yan-Ye [VerfasserIn]
Yang, Chao-Hui [VerfasserIn]
Lai, Chi-Chih [VerfasserIn]
Tsai, Wen-Ling [VerfasserIn]
Lin, Yu-Tsai [VerfasserIn]
Fang, Fu-Min [VerfasserIn]

Links:

Volltext

Themen:

Extranodal extension
Head and neck squamous cell carcinoma
Journal Article
Lymph node ratio
Lymphovascular invasion
Perineural invasion

Anmerkungen:

Date Completed 10.07.2023

Date Revised 16.11.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/hed.27428

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM357982738